Molecular Docking of Compounds Modulating Amyloid Peptide Aggregation Schemes

Author(s):  
S. Ginosyan ◽  
Y. Hambardzumyan ◽  
T. Mkrtchyan ◽  
H. Grabski ◽  
S. Tiratsuyan
2019 ◽  
Vol 13 ◽  
pp. 117906951986618 ◽  
Author(s):  
Suresh Kumar ◽  
Shivani Kumar ◽  
Heera Ram

Amyloidogenesis is the process in which amyloid beta (Aβ) peptide aggregation results in plaque formation in central nervous system (CNS) are associated with many neurological diseases such as Alzheimer’s disease. The peptide aggregation initiated from peptide monomers results in formation of dimers, tetramers, fibrils, and protofibrils. The ability of allicin, a lipid-soluble volatile organosulfur biological compound, present in freshly crushed garlic ( Allium sativum L.) to inhibit fibril formation by the Aβ peptide in vitro was investigated in the present study. Inhibition of fibrillogenesis was measured by a Thioflavin T (ThT) fluorescence assay and visualized by transmission electron microscopy (TEM). The molecular interaction between allicin and Aβ peptide was also demonstrated by in silico studies. The results show that allicin strongly inhibited Aβ fibrils by 97% at 300 µM, compared with control (Aβ only) ( P < .001). These results were further validated by visual of fibril formation by transmission microscopy and molecular interaction of amyloid peptide with allicin by molecular docking. Aβ forms favourable hydrophobic interaction with Ile32, Met35, Val36, and Val39, and oxygen of allicin forms hydrogen bond with the amino acid residue Lys28. Allicin anti-amyloidogenic property suggests that this naturally occurring compound may have potential to ameliorate and prevent Alzheimer’s disease.


2017 ◽  
Vol 159 ◽  
pp. 540-545 ◽  
Author(s):  
Israr Ahmad ◽  
Anbu Mozhi ◽  
Lin Yang ◽  
Qiusen Han ◽  
Xingjie Liang ◽  
...  

Nanoscale ◽  
2018 ◽  
Vol 10 (45) ◽  
pp. 20894-20913 ◽  
Author(s):  
Torsten John ◽  
Anika Gladytz ◽  
Clemens Kubeil ◽  
Lisandra L. Martin ◽  
Herre Jelger Risselada ◽  
...  

The accelerating and inhibiting effects of nanoparticles on amyloid peptide aggregation are discussed for varying nanoparticle and peptide properties in the context of recent studies.


2020 ◽  
Vol 10 (2) ◽  
pp. 194-199 ◽  
Author(s):  
Jiaojiao Hu ◽  
Huiyong Sun ◽  
Haiping Hao ◽  
Qiuling Zheng

2005 ◽  
Vol 38 (11) ◽  
pp. 885-891 ◽  
Author(s):  
Normand Mousseau ◽  
Philippe Derreumaux

2011 ◽  
Vol 7 ◽  
pp. S389-S390
Author(s):  
Marie-Lise Maddelein ◽  
Suzanna Dos Reis ◽  
Virginie Ramillon ◽  
Cyrielle Bonzom ◽  
Saad Mechiche Alami

Sign in / Sign up

Export Citation Format

Share Document